InMode Ltd. (INMD)
NASDAQ: INMD · Real-Time Price · USD
14.61
+0.10 (0.69%)
At close: Nov 12, 2025, 4:00 PM EST
14.57
-0.04 (-0.27%)
Pre-market: Nov 13, 2025, 8:52 AM EST
InMode Market Cap
InMode has a market cap or net worth of $923.49 million as of November 13, 2025. Its market cap has decreased by -39.30% in one year.
Market Cap
923.49M
Enterprise Value
396.77M
1-Year Change
-39.30%
Ranking
Category
Stock Price
$14.61
Market Cap Chart
Since August 8, 2019, InMode's market cap has increased from $433.88M to $923.49M, an increase of 112.84%. That is a compound annual growth rate of 12.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 12, 2025 | 923.49M | -34.65% |
| Dec 31, 2024 | 1.41B | -23.66% |
| Dec 29, 2023 | 1.85B | -37.59% |
| Dec 30, 2022 | 2.97B | -44.98% |
| Dec 31, 2021 | 5.39B | 218.85% |
| Dec 31, 2020 | 1.69B | 32.82% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Aug 8, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 909.35B |
| Johnson & Johnson | 468.54B |
| AbbVie | 413.29B |
| UnitedHealth Group | 308.76B |
| AstraZeneca | 275.24B |
| Novartis AG | 251.93B |
| Merck & Co. | 226.94B |
| Abbott Laboratories | 224.23B |